Byrne, Harriet http://orcid.org/0000-0001-7432-0945
Curtin, Claire http://orcid.org/0000-0001-7431-684X
Weadick, Catherine S. http://orcid.org/0000-0003-4823-7392
Riordáin, Rícheal Ní http://orcid.org/0000-0002-1937-8105
O’Reilly, Seamus http://orcid.org/0000-0002-2887-7336
Funding for this research was provided by:
CiSA
Article History
Received: 1 June 2024
Accepted: 10 September 2024
First Online: 28 September 2024
Declarations
:
: The ethical approval application was submitted to the Clinical Research Ethics Committee (CREC), University College Cork (UCC under the title “Oral Health Status and Dental Treatment Needs of Oncology Patients Receiving Bone Modifying Agents”. The research team included Dr Harriet Byrne (oral surgery speciality registrar), Professor Seamus O Reilly (consultant in medical oncology) and Professor Richeal Ní Riordáin (consultant in oral medicine). The stakeholders included University College Cork (UCC) and Health Service Executive (HSE), and the research project was conducted in the Oral Surgery Department, Cork University Dental School and Hospital, Wilton, Co Cork. The study was conducted in accordance with the requirements of the WMA Declaration of Helsinki (2008). Written informed consent will be obtained from all the participants.
: The authors affirm that human research participants provided informed consent for publication of the data and qualitative findings within this paper.
: Authors have no conflict of interest to declare.